AG˹ٷ

STOCK TITAN

[8-K] STERIS plc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Blue Bird Corp. (BLBD) delivered another quarter of double-digit growth. Q3 FY25 net sales climbed 19.4% YoY to $398 m on 14.7% higher bus shipments and favorable price/mix. Gross profit rose 24% to $85.9 m, expanding margin 80 bp to 21.6%. Operating income increased 26% to $50.1 m, and diluted EPS jumped 32% to $1.12.

Nine-month revenue reached $1.07 bn (+7%), with net income up 13% to $91.2 m ($2.76 diluted EPS). Operating cash flow more than doubled to $111.1 m, funding $38.9 m of share repurchases and boosting cash to $173.1 m. The revolver remains undrawn; term-loan principal fell to $92.5 m, cutting net leverage.

Working capital trends were mixed: inventories rose 18% to $151 m, while receivables dropped 64% to $21 m, supporting liquidity. Warranty and deferred-warranty liabilities edged higher. Order backlog stands near 3,900 units (-1,000 vs. FY24 year-end) but management characterizes demand as robust.

Management continues to battle supply-chain and tariff headwinds; pricing actions and manufacturing efficiencies are offsetting cost inflation. The newly enacted “One Big Beautiful Bill Act� could alter FY25 tax expense; the company is assessing the impact.

Blue Bird Corp. (BLBD) ha registrato un altro trimestre con una crescita a due cifre. Le vendite nette del terzo trimestre dell'anno fiscale 25 sono aumentate del 19,4% su base annua, raggiungendo 398 milioni di dollari, grazie a un incremento del 14,7% delle spedizioni di autobus e a un mix/prezzi favorevoli. Il profitto lordo è cresciuto del 24% a 85,9 milioni di dollari, con un'espansione del margine di 80 punti base al 21,6%. L'utile operativo è salito del 26% a 50,1 milioni di dollari, mentre l'utile per azione diluito è aumentato del 32% a 1,12 dollari.

I ricavi nei primi nove mesi hanno raggiunto 1,07 miliardi di dollari (+7%), con un utile netto in crescita del 13% a 91,2 milioni di dollari (utile per azione diluito di 2,76 dollari). Il flusso di cassa operativo è più che raddoppiato a 111,1 milioni di dollari, finanziando riacquisti di azioni per 38,9 milioni e aumentando la liquidità a 173,1 milioni. La linea di credito rotativa resta inutilizzata; il capitale del prestito a termine è sceso a 92,5 milioni, riducendo la leva finanziaria netta.

Le tendenze del capitale circolante sono state contrastanti: le scorte sono cresciute del 18% a 151 milioni di dollari, mentre i crediti sono diminuiti del 64% a 21 milioni, supportando la liquidità. Le passività per garanzia e garanzia differita sono leggermente aumentate. L'ordine arretrato si attesta vicino a 3.900 unità (-1.000 rispetto alla fine dell'anno fiscale 24), ma la direzione definisce la domanda come solida.

La direzione continua a fronteggiare difficoltà legate alla catena di approvvigionamento e ai dazi; le azioni sui prezzi e le efficienze produttive stanno compensando l'inflazione dei costi. Il nuovo "One Big Beautiful Bill Act" potrebbe modificare le imposte dell'anno fiscale 25; l'azienda sta valutando l'impatto.

Blue Bird Corp. (BLBD) presentó otro trimestre con crecimiento de dos dígitos. Las ventas netas del tercer trimestre del año fiscal 25 aumentaron un 19,4% interanual hasta 398 millones de dólares, impulsadas por un incremento del 14,7% en los envíos de autobuses y una combinación/precio favorable. El beneficio bruto subió un 24% hasta 85,9 millones de dólares, ampliando el margen en 80 puntos básicos hasta el 21,6%. El ingreso operativo creció un 26% hasta 50,1 millones de dólares, y el BPA diluido se disparó un 32% hasta 1,12 dólares.

Los ingresos en los primeros nueve meses alcanzaron los 1.070 millones de dólares (+7%), con un beneficio neto que aumentó un 13% hasta 91,2 millones de dólares (BPA diluido de 2,76 dólares). El flujo de caja operativo más que se duplicó hasta 111,1 millones de dólares, financiando recompras de acciones por 38,9 millones y aumentando el efectivo a 173,1 millones. La línea de crédito revolvente permanece sin utilizar; el principal del préstamo a plazo bajó a 92,5 millones, reduciendo el apalancamiento neto.

Las tendencias del capital de trabajo fueron mixtas: los inventarios subieron un 18% hasta 151 millones, mientras que las cuentas por cobrar cayeron un 64% hasta 21 millones, apoyando la liquidez. Las obligaciones por garantía y garantía diferida aumentaron ligeramente. La cartera de pedidos se sitúa cerca de 3.900 unidades (-1.000 respecto al cierre del ejercicio fiscal 24), pero la dirección califica la demanda como sólida.

La gerencia sigue enfrentando problemas en la cadena de suministro y aranceles; las acciones de precios y las eficiencias de fabricación están compensando la inflación de costos. La recién promulgada "One Big Beautiful Bill Act" podría modificar el gasto fiscal del ejercicio 25; la empresa está evaluando el impacto.

Blue Bird Corp. (BLBD)� � � 분기 � 자릿� 성장� 기록했습니다. 25회계연도 3분기 순매출은 전년 대� 19.4% 증가� 3� 9,800� 달러�, 버스 출하량이 14.7% 증가하고 가�/믹스가 유리하게 작용했습니다. 총이익은 24% 증가� 8,590� 달러�, 마진은 80bp 확대되어 21.6%� 기록했습니다. 영업이익은 26% 증가� 5,010� 달러, 희석 주당순이�(EPS)은 32% 상승� 1.12달러� 기록했습니다.

9개월 누적 매출은 10� 7,000� 달러(+7%)� 달했�, 순이익은 13% 증가� 9,120� 달러(희석 EPS 2.76달러)� 기록했습니다. 영업현금흐름은 � � 이상 증가� 1� 1,110� 달러�, 3,890� 달러� 자사� 매입� 자금� 투입하고 현금 보유액은 1� 7,310� 달러� 증가했습니다. 리볼� 신용은 사용되지 않았으며, 장기 대� 원금은 9,250� 달러� 감소� 순부� 비율� 줄었습니�.

운전자본 동향은 혼재됐습니다: 재고� 18% 증가� 1� 5,100� 달러� 반면, 매출채권은 64% 감소� 2,100� 달러� 유동성을 지원했습니�. 보증 � 이연 보증 부채는 다소 증가했습니다. 주문 잔고� � 3,900대(전년 � 대� 1,000대 감소) 수준이지�, 경영진은 수요가 견고하다� 평가하고 있습니다.

경영진은 공급� 문제와 관� 압박� 계속 대응하� 있으�, 가� 조정� 제조 효율� 개선으로 비용 상승� 상쇄하고 있습니다. 새로 제정� 'One Big Beautiful Bill Act'� 25회계연도 세금 비용� 변화를 가져올 � 있으�, 회사� 영향 평가� 진행 중입니다.

Blue Bird Corp. (BLBD) a enregistré un autre trimestre de croissance à deux chiffres. Les ventes nettes du troisième trimestre de l'exercice 25 ont augmenté de 19,4 % en glissement annuel pour atteindre 398 millions de dollars, grâce à une hausse de 14,7 % des livraisons de bus et à une combinaison/prix favorable. Le bénéfice brut a progressé de 24 % pour atteindre 85,9 millions de dollars, avec une marge en hausse de 80 points de base à 21,6 %. Le résultat d'exploitation a augmenté de 26 % pour atteindre 50,1 millions de dollars, et le BPA dilué a bondi de 32 % pour atteindre 1,12 $.

Le chiffre d'affaires sur neuf mois a atteint 1,07 milliard de dollars (+7 %), avec un bénéfice net en hausse de 13 % à 91,2 millions de dollars (BPA dilué de 2,76 $). Les flux de trésorerie d'exploitation ont plus que doublé pour atteindre 111,1 millions de dollars, finançant des rachats d'actions à hauteur de 38,9 millions et augmentant la trésorerie à 173,1 millions. La ligne de crédit renouvelable reste inutilisée; le principal du prêt à terme est tombé à 92,5 millions, réduisant l'effet de levier net.

Les tendances du fonds de roulement sont mitigées : les stocks ont augmenté de 18 % pour atteindre 151 millions, tandis que les créances ont chuté de 64 % à 21 millions, soutenant la liquidité. Les passifs liés aux garanties et garanties différées ont légèrement augmenté. Le carnet de commandes s'établit à environ 3 900 unités (-1 000 par rapport à la fin de l'exercice 24), mais la direction qualifie la demande de robuste.

La direction continue de faire face aux difficultés liées à la chaîne d'approvisionnement et aux tarifs douaniers; les actions tarifaires et les gains d'efficacité de fabrication compensent l'inflation des coûts. La nouvelle loi "One Big Beautiful Bill Act" pourrait modifier les charges fiscales de l'exercice 25; la société évalue actuellement l'impact.

Blue Bird Corp. (BLBD) erzielte erneut ein zweistelliges Wachstum im Quartal. Der Nettoumsatz im dritten Quartal des Geschäftsjahres 25 stieg im Jahresvergleich um 19,4 % auf 398 Mio. USD, bedingt durch 14,7 % mehr Buslieferungen und eine günstige Preis-/Mixentwicklung. Der Bruttogewinn wuchs um 24 % auf 85,9 Mio. USD, die Marge erhöhte sich um 80 Basispunkte auf 21,6 %. Das Betriebsergebnis stieg um 26 % auf 50,1 Mio. USD, und der verwässerte Gewinn je Aktie sprang um 32 % auf 1,12 USD.

Der Umsatz in den ersten neun Monaten erreichte 1,07 Mrd. USD (+7 %), der Nettogewinn stieg um 13 % auf 91,2 Mio. USD (verwässerter Gewinn je Aktie 2,76 USD). Der operative Cashflow mehr als verdoppelte sich auf 111,1 Mio. USD, finanzierte Aktienrückkäufe in Höhe von 38,9 Mio. USD und erhöhte die liquiden Mittel auf 173,1 Mio. USD. Die revolvierende Kreditlinie blieb ungenutzt; der Terminkredit sank auf 92,5 Mio. USD, wodurch die Nettoverschuldung reduziert wurde.

Die Entwicklung des Working Capital war gemischt: Die Lagerbestände stiegen um 18 % auf 151 Mio. USD, während die Forderungen um 64 % auf 21 Mio. USD zurückgingen, was die Liquidität unterstützte. Garantie- und latente Garantieverpflichtungen stiegen leicht an. Der Auftragsbestand liegt bei rund 3.900 Einheiten (-1.000 gegenüber dem Ende des Geschäftsjahres 24), aber das Management beschreibt die Nachfrage als robust.

Das Management kämpft weiterhin mit Herausforderungen in der Lieferkette und bei Zöllen; Preismaßnahmen und Fertigungseffizienzen gleichen die Kosteninflation aus. Das neu verabschiedete "One Big Beautiful Bill Act" könnte die Steueraufwendungen im Geschäftsjahr 25 verändern; das Unternehmen bewertet derzeit die Auswirkungen.

Positive
  • Q3 net sales up 19.4% YoY, reflecting higher volume and successful price increases.
  • Gross margin expanded 80 bp to 21.6%, despite inflation and tariffs.
  • Operating cash flow doubled to $111 m, lifting cash balance to $173 m.
  • No revolver borrowings and term-loan pay-down reduced net leverage and interest expense.
  • $38.9 m share repurchase retired ~1 m shares, enhancing per-share metrics.
Negative
  • Inventory rose 18% to $151 m, increasing working-capital risk if demand cools.
  • Order backlog fell ~20% to 3,900 units, signaling potential moderation in future revenue.
  • Warranty and deferred-warranty liabilities increased, which could pressure future margins.
  • Tariffs on imported components began impacting costs in Q3; further escalation remains possible.
  • Uncertainty over the One Big Beautiful Bill Act may alter FY25 effective tax rate.

Insights

TL;DR: Beat on revenue, margin expands, cash builds; tariff and tax uncertainties linger but overall trajectory remains favorable.

Revenue and EPS outpaced prior-year comps and street expectations, driven by higher volume and disciplined pricing. 80 bp gross-margin gain during an inflationary environment highlights management’s ability to pass through costs. Cash flow strength enabled nearly $39 m of buybacks, shrinking the float by ~3% YTD. Balance-sheet flexibility improved: $173 m cash, no revolver draws, and term debt amortizing on schedule. Inventories are elevated—likely a buffer against supply snags—yet receivable conversion mitigates risk. The 20% backlog reduction warrants monitoring but still equates to roughly six months of production. Upcoming guidance updates should address potential tax-rate changes under the One Big Beautiful Bill Act and incremental tariff exposure.

TL;DR: Market-share momentum in alt-fuel buses continues; supply chain and backlog dip are watch points.

Alternative-power buses generated nearly 63% of Q3 bus revenue, underscoring Blue Bird’s technological edge as districts pivot to propane and EV fleets. Extended warranty and parts revenue remain solid, supporting recurring profit streams. However, inventories +18% and higher deferred-warranty balances suggest cost pressure risk if demand slows. The drop from 4,900 to 3,900 units in backlog indicates order cadence normalizing after post-COVID surge. Still, with ~6,900 units shipped YTD, production cadence is matching historical norms. Net interest expense declined 34%, confirming benefit of deleveraging. Continued pricing discipline and operational efficiency will be vital to offset tariff-induced cost creep.

Blue Bird Corp. (BLBD) ha registrato un altro trimestre con una crescita a due cifre. Le vendite nette del terzo trimestre dell'anno fiscale 25 sono aumentate del 19,4% su base annua, raggiungendo 398 milioni di dollari, grazie a un incremento del 14,7% delle spedizioni di autobus e a un mix/prezzi favorevoli. Il profitto lordo è cresciuto del 24% a 85,9 milioni di dollari, con un'espansione del margine di 80 punti base al 21,6%. L'utile operativo è salito del 26% a 50,1 milioni di dollari, mentre l'utile per azione diluito è aumentato del 32% a 1,12 dollari.

I ricavi nei primi nove mesi hanno raggiunto 1,07 miliardi di dollari (+7%), con un utile netto in crescita del 13% a 91,2 milioni di dollari (utile per azione diluito di 2,76 dollari). Il flusso di cassa operativo è più che raddoppiato a 111,1 milioni di dollari, finanziando riacquisti di azioni per 38,9 milioni e aumentando la liquidità a 173,1 milioni. La linea di credito rotativa resta inutilizzata; il capitale del prestito a termine è sceso a 92,5 milioni, riducendo la leva finanziaria netta.

Le tendenze del capitale circolante sono state contrastanti: le scorte sono cresciute del 18% a 151 milioni di dollari, mentre i crediti sono diminuiti del 64% a 21 milioni, supportando la liquidità. Le passività per garanzia e garanzia differita sono leggermente aumentate. L'ordine arretrato si attesta vicino a 3.900 unità (-1.000 rispetto alla fine dell'anno fiscale 24), ma la direzione definisce la domanda come solida.

La direzione continua a fronteggiare difficoltà legate alla catena di approvvigionamento e ai dazi; le azioni sui prezzi e le efficienze produttive stanno compensando l'inflazione dei costi. Il nuovo "One Big Beautiful Bill Act" potrebbe modificare le imposte dell'anno fiscale 25; l'azienda sta valutando l'impatto.

Blue Bird Corp. (BLBD) presentó otro trimestre con crecimiento de dos dígitos. Las ventas netas del tercer trimestre del año fiscal 25 aumentaron un 19,4% interanual hasta 398 millones de dólares, impulsadas por un incremento del 14,7% en los envíos de autobuses y una combinación/precio favorable. El beneficio bruto subió un 24% hasta 85,9 millones de dólares, ampliando el margen en 80 puntos básicos hasta el 21,6%. El ingreso operativo creció un 26% hasta 50,1 millones de dólares, y el BPA diluido se disparó un 32% hasta 1,12 dólares.

Los ingresos en los primeros nueve meses alcanzaron los 1.070 millones de dólares (+7%), con un beneficio neto que aumentó un 13% hasta 91,2 millones de dólares (BPA diluido de 2,76 dólares). El flujo de caja operativo más que se duplicó hasta 111,1 millones de dólares, financiando recompras de acciones por 38,9 millones y aumentando el efectivo a 173,1 millones. La línea de crédito revolvente permanece sin utilizar; el principal del préstamo a plazo bajó a 92,5 millones, reduciendo el apalancamiento neto.

Las tendencias del capital de trabajo fueron mixtas: los inventarios subieron un 18% hasta 151 millones, mientras que las cuentas por cobrar cayeron un 64% hasta 21 millones, apoyando la liquidez. Las obligaciones por garantía y garantía diferida aumentaron ligeramente. La cartera de pedidos se sitúa cerca de 3.900 unidades (-1.000 respecto al cierre del ejercicio fiscal 24), pero la dirección califica la demanda como sólida.

La gerencia sigue enfrentando problemas en la cadena de suministro y aranceles; las acciones de precios y las eficiencias de fabricación están compensando la inflación de costos. La recién promulgada "One Big Beautiful Bill Act" podría modificar el gasto fiscal del ejercicio 25; la empresa está evaluando el impacto.

Blue Bird Corp. (BLBD)� � � 분기 � 자릿� 성장� 기록했습니다. 25회계연도 3분기 순매출은 전년 대� 19.4% 증가� 3� 9,800� 달러�, 버스 출하량이 14.7% 증가하고 가�/믹스가 유리하게 작용했습니다. 총이익은 24% 증가� 8,590� 달러�, 마진은 80bp 확대되어 21.6%� 기록했습니다. 영업이익은 26% 증가� 5,010� 달러, 희석 주당순이�(EPS)은 32% 상승� 1.12달러� 기록했습니다.

9개월 누적 매출은 10� 7,000� 달러(+7%)� 달했�, 순이익은 13% 증가� 9,120� 달러(희석 EPS 2.76달러)� 기록했습니다. 영업현금흐름은 � � 이상 증가� 1� 1,110� 달러�, 3,890� 달러� 자사� 매입� 자금� 투입하고 현금 보유액은 1� 7,310� 달러� 증가했습니다. 리볼� 신용은 사용되지 않았으며, 장기 대� 원금은 9,250� 달러� 감소� 순부� 비율� 줄었습니�.

운전자본 동향은 혼재됐습니다: 재고� 18% 증가� 1� 5,100� 달러� 반면, 매출채권은 64% 감소� 2,100� 달러� 유동성을 지원했습니�. 보증 � 이연 보증 부채는 다소 증가했습니다. 주문 잔고� � 3,900대(전년 � 대� 1,000대 감소) 수준이지�, 경영진은 수요가 견고하다� 평가하고 있습니다.

경영진은 공급� 문제와 관� 압박� 계속 대응하� 있으�, 가� 조정� 제조 효율� 개선으로 비용 상승� 상쇄하고 있습니다. 새로 제정� 'One Big Beautiful Bill Act'� 25회계연도 세금 비용� 변화를 가져올 � 있으�, 회사� 영향 평가� 진행 중입니다.

Blue Bird Corp. (BLBD) a enregistré un autre trimestre de croissance à deux chiffres. Les ventes nettes du troisième trimestre de l'exercice 25 ont augmenté de 19,4 % en glissement annuel pour atteindre 398 millions de dollars, grâce à une hausse de 14,7 % des livraisons de bus et à une combinaison/prix favorable. Le bénéfice brut a progressé de 24 % pour atteindre 85,9 millions de dollars, avec une marge en hausse de 80 points de base à 21,6 %. Le résultat d'exploitation a augmenté de 26 % pour atteindre 50,1 millions de dollars, et le BPA dilué a bondi de 32 % pour atteindre 1,12 $.

Le chiffre d'affaires sur neuf mois a atteint 1,07 milliard de dollars (+7 %), avec un bénéfice net en hausse de 13 % à 91,2 millions de dollars (BPA dilué de 2,76 $). Les flux de trésorerie d'exploitation ont plus que doublé pour atteindre 111,1 millions de dollars, finançant des rachats d'actions à hauteur de 38,9 millions et augmentant la trésorerie à 173,1 millions. La ligne de crédit renouvelable reste inutilisée; le principal du prêt à terme est tombé à 92,5 millions, réduisant l'effet de levier net.

Les tendances du fonds de roulement sont mitigées : les stocks ont augmenté de 18 % pour atteindre 151 millions, tandis que les créances ont chuté de 64 % à 21 millions, soutenant la liquidité. Les passifs liés aux garanties et garanties différées ont légèrement augmenté. Le carnet de commandes s'établit à environ 3 900 unités (-1 000 par rapport à la fin de l'exercice 24), mais la direction qualifie la demande de robuste.

La direction continue de faire face aux difficultés liées à la chaîne d'approvisionnement et aux tarifs douaniers; les actions tarifaires et les gains d'efficacité de fabrication compensent l'inflation des coûts. La nouvelle loi "One Big Beautiful Bill Act" pourrait modifier les charges fiscales de l'exercice 25; la société évalue actuellement l'impact.

Blue Bird Corp. (BLBD) erzielte erneut ein zweistelliges Wachstum im Quartal. Der Nettoumsatz im dritten Quartal des Geschäftsjahres 25 stieg im Jahresvergleich um 19,4 % auf 398 Mio. USD, bedingt durch 14,7 % mehr Buslieferungen und eine günstige Preis-/Mixentwicklung. Der Bruttogewinn wuchs um 24 % auf 85,9 Mio. USD, die Marge erhöhte sich um 80 Basispunkte auf 21,6 %. Das Betriebsergebnis stieg um 26 % auf 50,1 Mio. USD, und der verwässerte Gewinn je Aktie sprang um 32 % auf 1,12 USD.

Der Umsatz in den ersten neun Monaten erreichte 1,07 Mrd. USD (+7 %), der Nettogewinn stieg um 13 % auf 91,2 Mio. USD (verwässerter Gewinn je Aktie 2,76 USD). Der operative Cashflow mehr als verdoppelte sich auf 111,1 Mio. USD, finanzierte Aktienrückkäufe in Höhe von 38,9 Mio. USD und erhöhte die liquiden Mittel auf 173,1 Mio. USD. Die revolvierende Kreditlinie blieb ungenutzt; der Terminkredit sank auf 92,5 Mio. USD, wodurch die Nettoverschuldung reduziert wurde.

Die Entwicklung des Working Capital war gemischt: Die Lagerbestände stiegen um 18 % auf 151 Mio. USD, während die Forderungen um 64 % auf 21 Mio. USD zurückgingen, was die Liquidität unterstützte. Garantie- und latente Garantieverpflichtungen stiegen leicht an. Der Auftragsbestand liegt bei rund 3.900 Einheiten (-1.000 gegenüber dem Ende des Geschäftsjahres 24), aber das Management beschreibt die Nachfrage als robust.

Das Management kämpft weiterhin mit Herausforderungen in der Lieferkette und bei Zöllen; Preismaßnahmen und Fertigungseffizienzen gleichen die Kosteninflation aus. Das neu verabschiedete "One Big Beautiful Bill Act" könnte die Steueraufwendungen im Geschäftsjahr 25 verändern; das Unternehmen bewertet derzeit die Auswirkungen.

0001757898Dublin 2,falseD02 R2962025-07-31353001-38848L2falsefalsefalse00017578982025-07-312025-07-310001757898ste:OrdinarySharesMember2025-07-312025-07-310001757898ste:STETwo700SeniorNotesDue2031MemberMember2025-07-312025-07-310001757898ste:Two700SeniorNotesDue2051MemberMember2025-07-312025-07-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2025

STERIS plc
(Exact Name of Registrant as Specified in Charter)
Ireland001-38848 98-1455064
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(IRS Employer
Identification No.)
70 Sir John Rogerson's Quay,Dublin 2,IrelandD02 R296
(Address of principal executive offices)
Registrant’s telephone number, including area code: + 353 1 232 2000

Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange
on which registered
Ordinary Shares, $0.001 par valueSTENew York Stock Exchange
2.700% Senior Notes due 2031STE/31New York Stock Exchange
3.750% Senior Notes due 2051STE/51New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.02Results of Operations and Financial Condition.

On August 6, 2025, STERIS plc (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of this press release is attached hereto as Exhibit 99.1.

The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that Section. Furthermore, the information contained in this Item 2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933.

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Chief Financial Officer

On July 31, 2025, Michael J. Tokich notified the Board of Directors (the “Board”) of his resignation from his current role as Senior Vice President and Chief Financial Officer of the Company.

Mr. Tokich and the Company have entered into a Transition Agreement, dated August 5, 2025 (the “Transition Agreement”). The Transition Agreement will take effect on August 18, 2025. The Transition Agreement provides for a continuation of Mr. Tokich’s employment with the Company as a senior financial advisor until March 31, 2026 (the “Senior Advisor Period”), subject to potential termination by the Company for “Cause” or because of Mr. Tokich’s death or “Disability” (“Cause” and “Disability” used as defined in the Transition Agreement), by the Company after January 1, 2026 for any reason or by Mr. Tokich at any time for any reason. The Transition Agreement further provides that during the Senior Advisor Period, Mr. Tokich’s annual base salary rate will be reduced to $427,450.14 but his other outstanding awards will remain in place (including his bonus target under the Company’s Management and Incentive Compensation Plan (“MICP”) at his previous salary rate). Subject to the terms of the Transition Agreement, Mr. Tokich’s outstanding but unvested equity awards granted in October 2021 and June 2022 will continue to vest and be eligible for continued “retirement” vesting and exercisability on the same terms as similar equity awards made subsequent to May 30, 2023. The Company, at its sole discretion, may extend the Senior Advisor Period by up to six months, and Mr. Tokich will be entitled to continue receiving his base salary and be eligible for a prorated bonus under the MICP during such extended term at his new salary. Any bonuses achieved under the MICP will be at the sole discretion of the Company’s Compensation and Organization Development Committee and subject to the terms of the MICP.

Through the end of the Senior Advisor Period or the termination of the Transition Agreement, Mr. Tokich will be entitled to continuing benefits under the Company’s health and dental plans as well as any life insurance, vacation, disability or other employee benefit plans or programs. No severance plan benefits will be payable to Mr. Tokich. However, should Mr. Tokich’s employment be terminated by the Company without “Cause” (as defined in the Transition Agreement), he would be entitled to receive the remainder of his salary during the Senior Advisor Period (subject to the execution of a mutually satisfactory release agreement), his MICP bonus and a continuation of benefits through March 31, 2026.

Appointment of Chief Financial Officer

Effective August 18, 2025, Karen Burton will become the Senior Vice President and Chief Financial Officer of the Company. In connection with Ms. Burton’s appointment, her base salary will increase to an annual rate of $600,000 and her target bonus opportunity under the MICP will increase to 75% of base salary. She will also receive an equity award consisting of restricted stock and stock options with an aggregate value of approximately $1,134,000, with such awards to be made effective on October 1, 2025. Severance plan benefits for Ms. Burton will continue to be subject to the terms of the STERIS plc Senior Executive Severance Plan.

Ms. Burton, age 58, has served as the Vice President and Chief Accounting Officer of the Company since January 2017, and previously served as Controller from May 2008 until December 2023.

On August 6, 2025, the Company issued a press release announcing the Chief Financial Officer transition described in this Item 5.02. A copy of this press release is attached hereto as Exhibit 99.2.









Item 5.07Submission of Matters to a Vote of Security Holders.

At the 2025 Annual General Meeting of Shareholders (“Meeting”) of STERIS plc (the “Company”) held on July 31, 2025, shareholders voted on the matters specified below, with the final voting results as specified. According to the final report of the inspector of election, there were 98,370,979 Ordinary Shares of the Company outstanding and entitled to vote at the Meeting. There were present at the Meeting, in person or by proxy, the holders of 90,352,951 Ordinary Shares or 91.84% of the outstanding Ordinary Shares of the Company on the record date, constituting a quorum.

The shareholders elected the nominees named below to the board of directors of the Company (the “Board”), each for a one-year term, and the results of the vote were as follows:

NomineeVotes forVotes againstAbstentionsBroker non-votes
Esther M. Alegria
84,864,789
1,319,157
186,777
3,982,228
Richard C. Breeden
82,042,813
4,128,905
199,005
3,982,228
Daniel A. Carestio
85,698,132
599,888
72,703
3,982,228
Cynthia L. Feldmann
80,026,631
5,897,558
446,534
3,982,228
Christopher S. Holland
85,632,351
641,393
96,979
3,982,228
Paul E. Martin
85,061,615
1,211,856
97,252
3,982,228
Dr. Nirav R. Shah
84,128,567
2,161,658
80,498
3,982,228
Louis A. Shapiro
85,875,558
399,737
95,428
3,982,228
Dr. Mohsen M. Sohi
77,404,543
8,689,139
277,041
3,982,228

The shareholders approved the proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2026 by the following votes:

Votes for81,422,252
Votes against8,877,660
Abstentions53,039

The shareholders approved the proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes:

Votes for81,668,746
Votes against8,631,098
Abstentions53,107

The shareholders approved the proposal to authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes:

Votes for89,454,279
Votes against836,945
Abstentions61,727

The shareholders approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2025, by the following votes:






Votes for77,678,574
Votes against8,498,219
Abstentions193,930
Broker non-votes3,982,228

The shareholders approved the proposal to the renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes:

Votes for88,740,375
Votes against1,500,730
Abstentions111,846

The shareholders approved the proposal to approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes:

Votes for84,751,658
Votes against5,339,554
Abstentions261,739








































Item 9.01Financial Statements and Exhibits.
(d) Exhibits:
Exhibit
No.
  Description
99.1  
Press Release issued by STERIS plc on August 6, 2025 announcing financial results for its fiscal 2026 first quarter ending June 30, 2025.
99.2
Press Release issued by STERIS plc on August 6, 2025 announcing the Chief Financial Officer transition.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
STERIS plc
By /s/ J. Adam Zangerle
Name: J. Adam Zangerle
Title: Senior Vice President, General Counsel & Company Secretary
Dated: August 6, 2025


FAQ

How much did Blue Bird's (BLBD) revenue grow in Q3 FY25?

Net sales increased 19.4% year-over-year to $398.0 million.

What were Blue Bird's Q3 FY25 earnings per share?

Diluted EPS rose to $1.12, up from $0.85 in the prior-year quarter.

How strong is Blue Bird's cash position after nine months of FY25?

Cash and equivalents total $173.1 million, with no revolver borrowings outstanding.

What is the status of Blue Bird's share repurchase program?

The company bought back $38.9 million of stock YTD; $11.1 million authorization remains.

How are supply-chain issues and tariffs affecting Blue Bird?

Management reports continued component shortages and new tariff-driven cost increases but states that pricing actions are offsetting most inflation.

What is Blue Bird's current backlog?

Backlog is approximately 3,900 buses, down from ~4,900 at FY24 year-end.
Steris Plc

NYSE:STE

STE Rankings

STE Latest News

STE Latest SEC Filings

STE Stock Data

22.02B
98.06M
0.3%
95.58%
0.86%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
United States
DUBLIN